Literature DB >> 16002191

Model selection methodology for inter-laboratory standardisation of antibody titres.

George Kafatos1, Nick Andrews, Anthony Nardone.   

Abstract

The aim of the European Sero-Epidemiology Network 2 (ESEN2) is to compare standardised serological results of vaccine preventable diseases across Europe. In order to adjust for laboratory and assay differences, the participant laboratories tested a standardisation panel for each disease and the results were plotted against those of a reference centre in order to obtain standardisation equations. We describe an algorithm for obtaining these equations which took into account outliers, censored data and model selection, and needed to be robust due to the variety of assays and diseases under investigation. If the standardisation equations explained sufficient variability, these were used to convert each country's main serum bank results to a common unitage, thereby allowing international comparisons to be made.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16002191     DOI: 10.1016/j.vaccine.2005.05.030

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  11 in total

1.  Standardization of measles, mumps and rubella assays to enable comparisons of seroprevalence data across 21 European countries and Australia.

Authors:  A Tischer; N Andrews; G Kafatos; A Nardone; G Berbers; I Davidkin; Y Aboudy; J Backhouse; C Barbara; K Bartha; B Bruckova; A Duks; A Griskevicius; L Hesketh; K Johansen; L Jones; O Kuersteiner; E Lupulescu; Z Mihneva; M Mrazova; F De Ory; K Prosenc; F Schneider; A Tsakris; M Smelhausova; R Vranckx; M Zarvou; E Miller
Journal:  Epidemiol Infect       Date:  2007-03-30       Impact factor: 2.451

2.  Towards elimination: measles susceptibility in Australia and 17 European countries.

Authors:  Nick Andrews; Annedore Tischer; Annette Siedler; Richard G Pebody; Christopher Barbara; Suzanne Cotter; Arnis Duks; Nina Gacheva; Kriz Bohumir; Kari Johansen; Joel Mossong; Fernando de Ory; Katarina Prosenc; Margareta Sláciková; Heidi Theeten; Marios Zarvou; Adriana Pistol; Kalman Bartha; Dani Cohen; Jo Backhouse; Algirdas Griskevicius
Journal:  Bull World Health Organ       Date:  2008-03       Impact factor: 9.408

3.  Comparison of rubella seroepidemiology in 17 countries: progress towards international disease control targets.

Authors:  Anthony Nardone; Annedore Tischer; Nick Andrews; Jo Backhouse; Heidi Theeten; Nina Gatcheva; Marios Zarvou; Bohumir Kriz; Richard G Pebody; Kalman Bartha; Darina O'Flanagan; Dani Cohen; Arnis Duks; Algirdas Griskevicius; Joel Mossong; Christopher Barbara; Adrianna Pistol; Margareta Slaciková; Katarina Prosenc; Kari Johansen; Elizabeth Miller
Journal:  Bull World Health Organ       Date:  2008-02       Impact factor: 9.408

4.  The seroepidemiology of varicella zoster virus among pregnant Bangladeshi and white British women in the London Borough of Tower Hamlets, UK.

Authors:  Y S Talukder; G Kafatos; A Pinot de Moira; J Aquilina; S P Parker; N S Crowcroft; D W G Brown; J Breuer
Journal:  Epidemiol Infect       Date:  2007-04-20       Impact factor: 2.451

5.  Comparative seroepidemiology of diphtheria in six European countries and Israel.

Authors:  P di Giovine; G Kafatos; A Nardone; N Andrews; R M Ölander; G Alfarone; K Broughton; D Cohen; B Kriz; I Mikova; D O'Flanagan; F Schneider; I Selga; L Valinsky; I Velicko; I Karacs; R Pebody; C von Hunolstein
Journal:  Epidemiol Infect       Date:  2012-02-24       Impact factor: 4.434

6.  Seroepidemiology of mumps in Europe (1996-2008): why do outbreaks occur in highly vaccinated populations?

Authors:  J Eriksen; I Davidkin; G Kafatos; N Andrews; C Barbara; D Cohen; A Duks; A Griskevicius; K Johansen; K Bartha; B Kriz; G Mitis; J Mossong; A Nardone; D O'Flanagan; F DE Ory; A Pistol; H Theeten; K Prosenc; M Slacikova; R Pebody
Journal:  Epidemiol Infect       Date:  2012-06-12       Impact factor: 4.434

7.  Comparative hepatitis A seroepidemiology in 10 European countries.

Authors:  S Kurkela; R Pebody; G Kafatos; N Andrews; C Barbara; B Bruzzone; D Butur; S Caplinskas; I Davidkin; A Hatzakis; W Hellenbrand; L M Hesketh; A Nardone; V Nemecek; A Pistol; Z Sobotová; R Vranckx; C G Anastassopoulou
Journal:  Epidemiol Infect       Date:  2012-01-25       Impact factor: 4.434

8.  Estimating seroprevalence of vaccine-preventable infections: is it worth standardizing the serological outcomes to adjust for different assays and laboratories?

Authors:  G Kafatos; N Andrews; K J McConway; C Anastassopoulou; C Barbara; F De Ory; K Johansen; J Mossong; K Prosenc; R Vranckx; A Nardone; R Pebody; P Farrington
Journal:  Epidemiol Infect       Date:  2014-11-25       Impact factor: 4.434

9.  Universal hepatitis B vaccination in Belgium: impact on serological markers 3 and 7 years after implementation.

Authors:  H Theeten; V Hutse; K Hoppenbrouwers; P Beutels; P VAN Damme
Journal:  Epidemiol Infect       Date:  2013-05-21       Impact factor: 4.434

10.  Seroepidemiology of varicella zoster virus infection in Vojvodina, Serbia.

Authors:  S Medić; V Petrović; V Milosević; Z Lozanov-Crvenković; S Brkić; N Andrews; F de Ory; C Anastassopoulou
Journal:  Epidemiol Infect       Date:  2018-06-18       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.